A class of tripterine derivatives, its preparation method and use
A technology of tripterine and its derivatives, which is applied in the field of medicines for diseases and the preparation of peroxidase inhibitors, and can solve problems such as weak activity, complex mechanism of action, and unclear targets
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example 1
[0054] Preparation Example 1: Preparation of Compound 1-1
[0055]
[0056] Dissolve tripterine (1g, 2.2mmol) in toluene (10ml), add DIPEA (1.16ml, 6.7mmol) and diphenylphosphoryl azide (0.62ml, 2.9mmol) to the solution, and stir at 100°C 3 hours. The reaction solution was diluted with ethyl acetate, extracted with water, the organic layer was washed with saturated brine, dried over anhydrous sodium sulfate, spin-dried, and separated by silica gel column chromatography (PE:EA=6:1) to obtain 610 mg of a red solid (yield 62 %). 1 H NMR (400MHz, CDCl 3 )δ7.03(d,J=6.0Hz,2H),6.54–6.50(m,1H),6.36(d,J=7.1Hz,1H),2.21(s,3H),2.16–2.05(m,2H ),1.96–1.86(m,3H),1.82–1.64(m,6H),1.60–1.51(m,3H),1.43(s,3H),1.40(s,3H),1.25(s,3H), 1.05(s,3H), 1.03–0.97(m,1H), 0.92(s,3H).
Embodiment 1
[0057] Embodiment 1: the preparation of compound S1
[0058]
[0059] Compound 1-1 (50mg, 0.11mmol) was dissolved in tetrahydrofuran (2ml), and ethyl 1-aminocyclopropanecarboxylate hydrochloride (37mg, 0.22mmol), triethylamine (31μl, 0.22mmol) were added to the solution ), stirred at 50°C for 4 hours, spin-dried the solvent, dissolved it with ethyl acetate, extracted with water, washed the organic layer with saturated brine, dried over anhydrous sodium sulfate, spin-dried, and separated by silica gel column chromatography (DCM:MeOH=30:1 ), to obtain 42 mg of red solid (65% yield). 1 H NMR (400MHz, CDCl 3 )δ7.01(d, J=8.5Hz, 2H), 6.51(s, 1H), 6.35(d, J=6.9Hz, 1H), 4.93(s, 1H), 4.38(s, 1H), 4.07( q,J=7.2Hz,2H),2.89(d,J=14.0Hz,1H),2.20(s,3H),2.11(dd,J=12.8,4.4Hz,1H),2.02–1.60(m,10H ),1.53(m,J=9.1Hz,5H),1.37(s,3H),1.26(s,3H),1.17(t,J=7.1Hz,3H),1.10(s,3H),0.98(m ,2H), 0.75(s,3H). MS(ESI): [M+Na] + m / z 599.4
Embodiment 2
[0060] Embodiment 2: the preparation of compound S2
[0061]
[0062]Compound 1-1 (50mg, 0.11mmol) was dissolved in tetrahydrofuran (2ml), and methyl 1-aminocyclobutanecarboxylate hydrochloride (36mg, 0.22mmol), triethylamine (31μl, 0.22mmol) were added to the solution , stirred at 50°C for 4 hours, spin-dried the solvent, dissolved it with ethyl acetate, extracted with water, washed the organic layer with saturated brine, dried over anhydrous sodium sulfate, spin-dried, and separated by silica gel column chromatography (DCM:MeOH=30:1) , to obtain 45 mg of red solid (yield 71%). 1 H NMR (400MHz, CDCl 3 )δ7.02(d, J=8.6Hz, 2H), 6.49(s, 1H), 6.36(d, J=6.3Hz, 1H), 5.05(s, 1H), 4.35(s, 1H), 3.69( s,3H),2.89(d,J=15.4Hz,1H),2.49(d,J=38.2Hz,2H),2.20(s,3H),1.93(d,J=15.4Hz,7H),1.70( dd,J=12.8,5.9Hz,2H),1.62–1.47(m,6H),1.41(s,3H),1.34(s,3H),1.24(s,3H),1.09(s,3H),0.94 (d, J=12.4Hz, 1H), 0.80(s, 3H). MS(ESI): [M+Na] + m / z 599.4
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


